CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Self-citationHoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Self-citationBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Self-citationChan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Self-citationMeta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701
Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
Dwan, K., Gamble, C., Williamson, P. R., Kirkham, J. J., & the Reporting Bias Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0066844 · Cited by 1,127
Prevalence of multimorbidity among adults seen in family practice
Fortin, M. (2005) · The Annals of Family Medicine · doi:10.1370/afm.272 · Cited by 987
Research works printed but not linked: 83
- Gitterman, 2008, That sinking feeling, again? the state of national institutes of health pediatric research funding, fiscal year 1992-2010, Pediatr Res, 64, 462, 10.1203/PDR.0b013e31818912fd · DOI
- Gagne, 2014, Innovative research methods for studying treatments for rare diseases: methodological review, BMJ, 349, g6802, 10.1136/bmj.g6802 · DOI · Paper page
- Fortin, 2006, Randomized controlled trials: do they have external validity for patients with multiple comorbidities?, Ann Fam Med, 4, 104, 10.1370/afm.516 · DOI · Paper page
- Zarin, 2005, Challenges to evidence-based medicine, Soc Psychiatry Psychiatr Epidemiol, 40, 27, 10.1007/s00127-005-0838-9 · DOI
- Schwartz, 2009, Explanatory and pragmatic attitudes in therapeutical trials, J Clin Epidemiol, 62, 499, 10.1016/j.jclinepi.2009.01.012 · DOI · Paper page
- Van den Akker, 1998, Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases, J Clin Epidemiol, 51, 367, 10.1016/S0895-4356(97)00306-5 · DOI · Paper page
- Zucker, 1997, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, J Clin Epidemiol, 50, 401, 10.1016/S0895-4356(96)00429-5 · DOI · Paper page
- OCEBM Levels of Evidence Working Group. The Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine, 2011. Available at www.cebm.net/index.aspx?o55653. Accessed December 14, 2014.
- Hersen, 1990, Chapter 9: Single-case experimental designs, 175
- Glasziou, 2014, Reducing waste from incomplete or unusable reports of biomedical research, Lancet, 383, 267, 10.1016/S0140-6736(13)62228-X · DOI · Paper page
- Tate, 2012, Developing reporting guidelines for single-case experimental designs: the SCRIBE project, Brain Impairment, 13, 135
- Turner L, Moher D, Shamseer L, Weeks L, Peters J, Plint A, et al. The influence of CONSORT on the quality of RCTs: an updated review. 9th Annual Cochrane Canada Symposium, 2011.
- Vohra, 2015, CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement, BMJ, 350, h1738, 10.1136/bmj.h1738 · DOI · Paper page
- Moher, 2010, Guidance for developers of health research reporting guidelines, Plos Med, 7, e1000217, 10.1371/journal.pmed.1000217 · DOI · Paper page
- Price, 2002, An N-of-1 randomized controlled trial (‘N-of-1 trial’) of donepezil in the treatment of non-progressive amnestic syndrome, Age Ageing, 31, 307, 10.1093/ageing/31.4.307 · DOI
- Wegman, 2005, Efficacy of temazepam in frequent users: a series of N-of-1 trials, Fam Pract, 22, 152, 10.1093/fampra/cmh726 · DOI
- Träder, 2007, Mutterkraut als prophylaktische phytotherapie bei migräne: N-of-1-studie zum individuellen wirksamkeitsnachweis [feverfew as preventive therapy for migraine: N-of-1-trial for verification of individual efficacy], ZFA, 83, 238, 10.1055/s-2007-977710 · doi:10.1055/s-2007-977710
- Nonoyama, 2007, Effect of oxygen on health quality of life in COPD patients with transient exertional hypoxemia, Am J Respir Crit Care Med, 176, 343, 10.1164/rccm.200702-308OC · DOI
- Pereira, 2005, Are brand-name and generic warfarin interchangeable? multiple n-of-1 randomized, crossover trials, Ann Pharmacother, 39, 1188, 10.1345/aph.1G003 · DOI
- Kamien, 1998, The use of an N-of-1 randomised clinical trial in resolving therapeutic doubt. the case of a patient with an ‘attention disorder’, Aust Fam Physician, 27, S103
- Sung, 2007, Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients, Eur J Cancer, 43, 1269, 10.1016/j.ejca.2007.02.001 · DOI
- Louly, 2009, N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough, Clin Ther, 31, 1007, 10.1016/j.clinthera.2009.05.015 · doi:10.1016/j.clinthera.2009.05.015
- Wegman, 2003, de HM, Deville WL, Fo CT, de Vries TP. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis, Ann Rheum Dis, 62, 1156, 10.1136/ard.2002.002865 · DOI
- Smith, 2004, Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol, Chron Respir Dis, 1, 63, 10.1191/1479972304cd028oa · DOI
- Johannessen, 1992, Cimetidine on-demand in dyspepsia. experience with randomized controlled single-subject trials, Scand J Gastroenterol, 27, 189, 10.3109/00365529208999947 · DOI
- Fedele, 1993, Effects of medication on parotid salivary flow rates in an individual with dementia of the alzheimer type, Spec Care Dentist, 13, 215, 10.1111/j.1754-4505.1993.tb01499.x · DOI
- Coxeter, 2003, Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials, Complement Ther Med, 11, 215, 10.1016/S0965-2299(03)00122-5 · DOI
- Nathan, 2006, A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a bayesian randomized serial N-of-1 trials design, Support Care Cancer, 14, 268
- Irwig, 1995, Ethics of n-of-1 trials, Lancet, 345, 469, 10.1016/S0140-6736(95)90578-2 · DOI
- Mahon, 1995, Ethics of n-of-1 trials, Lancet, 345, 989, 10.1016/S0140-6736(95)90738-6 · DOI
- Zucker, 2010, Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations, J Clin Epidemiol, 63, 1312, 10.1016/j.jclinepi.2010.04.020 · DOI · Paper page
- Punja S, Eslick I, Duan N, Vohra S, the DEcIDE Methods Center N-of-1 Guidance Panel. Chapter 2: An ethical framework for N-of-1 trials: clinical care, quality improvement, or human subjects research? In: Kravitz RL, Duan N, and the DEcIDE Methods Center N-of-1 Guidance Panel, eds. Design and implementation of N-of-1 trials: a user’s guide. AHRQ Publication No 13(14)-EHC122-EF. Agency for Healthcare Research and Quality, 2014:13–22.
- Guyatt, 1986, Determining optimal therapy–randomized trials in individual patients, N Engl J Med, 314, 889, 10.1056/NEJM198604033141406 · DOI · Paper page
- Gagnier, 2006, Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration, J Clin Epidemiol, 59, 1134, 10.1016/j.jclinepi.2005.12.020 · DOI · Paper page
- MacPherson, 2010, Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): Extending the CONSORT statement, Acupunct Med, 28, 83, 10.1136/aim.2009.001370 · DOI · Paper page
- McLeod, 1986, Single-patient randomised clinical trial. use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir, Lancet, 1, 726, 10.1016/S0140-6736(86)91112-8 · DOI
- Guyatt, 2004, Patients at the center: in our practice, and in our use of language, ACP J Club, 140, A11, 10.7326/ACPJC-2004-140-1-A11 · DOI · Paper page
- Gandhi, 2008, Patient-important outcomes in registered diabetes trials, JAMA, 299, 2543, 10.1001/jama.299.21.2543 · DOI · Paper page
- Paterson, 1996, Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey, BMJ, 312, 1016, 10.1136/bmj.312.7037.1016 · DOI · Paper page
- Paterson, 2005, A pilot study of therapeutic massage for people with parkinson’s disease: the added value of user involvement, Complement Ther Clin Pract, 11, 161, 10.1016/j.ctcp.2004.12.008 · DOI
- Dziegielewski, 2000, Eye movement desensitization and reprocessing (EMDR) as a time-limited treatment intervention for body image disturbance and self-esteem: a single subject case study design, J Psychother Independent Pract, 1, 1, 10.1300/J288v01n03_01 · DOI
- Johnston, 2010, Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review, Pediatrics, 126, e222, 10.1542/peds.2009-3667 · DOI · Paper page
- Sinha, 2012, Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children, Pediatrics, 129, S146, 10.1542/peds.2012-0055H · DOI
- Miyar, 2013, Content and quality of 10,000 controlled trials in schizophrenia over 60 years, Schizophr Bull, 39, 226, 10.1093/schbul/sbr140 · DOI
- Zwaigenbaum, 2006, “N of 1” trials of methylphenidate in two children with Williams syndrome and attention deficit hyperactivity disorder, J Dev Phys Disabil, 18, 45, 10.1007/s10882-006-9005-9 · DOI
- Nikles, 2011, Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care, J Clin Epidemiol, 64, 471, 10.1016/j.jclinepi.2010.05.009 · DOI
- Cepeda, 2008, An N-of-1 trial as an aid to decision-making prior to implanting a permanent spinal cord stimulator, Pain Med, 9, 235, 10.1111/j.1526-4637.2007.00329.x · DOI
- Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
- Bassler, 2010, Stopping randomized trials early for benefit and estimation of treatment effects, JAMA, 303, 1180, 10.1001/jama.2010.310 · DOI · Paper page
- Nikles, 2005, Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain?, Am J Ther, 12, 92, 10.1097/00045391-200501000-00012 · DOI
- Morrow, 2006, Comparing fixed- and randomized-interval spaced retrieval in anomia treatment, J Commun Disord, 39, 2, 10.1016/j.jcomdis.2005.05.001 · DOI
- Schmid CH, Duan N, the DEcIDE Methods Center N-of-1 Guidance Panel. Chapter 4: Statistical design and analytic considerations for N-of-1 trials. In: Kravitz RL, Duan N, DEcIDE Methods Center N-of-1 Guidance Panel, editors. Design and implementation of N-of-1 trials: a user’s guide. AHRQ Publication No 13(14)-EHC122-EF ed. Agency for Healthcare Research and Quality, 2014:33–53.
- Woodfield, 2005, N-of-1 trials of quinine efficacy in skeletal muscle cramps of the leg, Br J Gen Pract, 55, 181
- Price, 2002, N-of-1 randomized controlled trials (‘N-of-1 trials’): singularly useful in geriatric medicine, Age Ageing, 31, 227, 10.1093/ageing/31.4.227 · doi:10.1093/ageing/31.4.227
- Arroll, 1989, Single case randomised trial of tryptophan vs placebo, NZ Fam Physician, 16, 14
- International Committee of Medical Journal Editors, 1997, Uniform requirements for manuscripts submitted to biomedical journals, Ann Intern Med, 126, 36, 10.7326/0003-4819-126-1-199701010-00006 · DOI · Paper page
- Gage, 2013, Analysis of effect for single-case design research, J Appl Sport Psychol, 25, 46, 10.1080/10413200.2012.660673 · DOI
- Horner, 2012, Considerations for the systematic analysis and use of single-case research, Educ Treat Child, 35, 269, 10.1353/etc.2012.0011 · DOI · Paper page
- Heyvaert, 2014, Randomization and data-analysis items in quality standards for single-case experimental studies, J Spec Educ
- Shadish, 2014, Statistical analyses of single-case designs the shape of things to come, Curr Direct Psychol Sci, 23, 139, 10.1177/0963721414524773 · DOI · Paper page
- Bailar, 1988, Guidelines for statistical reporting in articles for medical journals. amplifications and explanations, Ann Intern Med, 108, 266, 10.7326/0003-4819-108-2-266 · DOI · Paper page
- Zucker, 2006, Lessons learned combining N-of-1 trials to assess fibromyalgia therapies, J Rheumatol, 33, 2069
- Maggin, 2011, A quantitative synthesis of methodology in the meta-analysis of single-subject research for students with disabilities: 1985–2009, Exceptionality, 19, 109, 10.1080/09362835.2011.565725 · DOI · Paper page
- Gage, 2012, Hierarchical linear modeling meta-analysis of single-subject design research, J Spec Educ
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 · DOI · Paper page
- Haas, 2004, Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache, Headache, 44, 1029, 10.1111/j.1526-4610.2004.04199.x · DOI
- Maggin, 2011, A generalized least squares regression approach for computing effect sizes in single-case research: application examples, J Sch Psychol, 49, 301, 10.1016/j.jsp.2011.03.004 · DOI
- Rochon, 1990, A statistical model for the “N-of-1” study, J Clin Epidemiol, 43, 499, 10.1016/0895-4356(90)90139-G · DOI
- Parker, 2007, Percentage of all non-overlapping data (PAND) an alternative to PND, J Spec Educ, 40, 194, 10.1177/00224669070400040101 · DOI · Paper page
- Johnston, 2010, Single subject designs: current methodologies and future directions, OTJR, 30, 4
- Gordon, 1996, Valproic acid treatment of learning disorder and severely epileptiform EEG without clinical seizures, J Child Neurol, 11, 41, 10.1177/088307389601100110 · DOI
- Dales, 1992, Chronic cough responsive to ibuprofen, Pharmacotherapy, 12, 331, 10.1002/j.1875-9114.1992.tb04467.x · doi:10.1002/j.1875-9114.1992.tb04467.x
- Estrada, 1993, Patient preferences for novel therapy: an N-of-1 trial of garlic in the treatment for hypertension, J Gen Intern Med, 8, 619, 10.1007/BF02599719 · doi:10.1007/bf02599719
- Lehman, 2012, Missing clinical trial data, BMJ, 344, 10.1136/bmj.d8158 · DOI
- Avins, 2005, Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study, Contemp Clin Trials, 26, 397, 10.1016/j.cct.2005.02.004 · doi:10.1016/j.cct.2005.02.004
- Reed, 2005, AB/BA crossover trials-binary outcome, J Mod App Stat Meth, 5, 19, 10.22237/jmasm/1162354680 · doi:10.22237/jmasm/1162354680
- Johannessen, 1991, The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. combined results from randomized, controlled, single-subject trials, Scand J Gastroenterol, 26, 974, 10.3109/00365529108996251 · DOI
- Yelland, 2007, Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials, Rheumatology (Oxford), 46, 135, 10.1093/rheumatology/kel195 · DOI · Paper page
- Van, 1995, N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury, Brain Inj, 9, 49, 10.3109/02699059509004571 · DOI · Paper page
- Nikles, 2006, An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder, Pediatrics, 117, 2040, 10.1542/peds.2005-1328 · DOI
- Tison, 2013, Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin against levodopa-induced dyskinesia in parkinson’s disease patients, Parkinsonism Relat Disord, 19, 416, 10.1016/j.parkreldis.2012.12.003 · DOI
- Paz-Filho, 2008, Leptin replacement improves cognitive development, PLoS One, 3, e3098, 10.1371/journal.pone.0003098 · DOI · Paper page
- Chalmers, 2009, Avoidable waste in the production and reporting of research evidence, Obstet Gynecol, 114, 1341, 10.1097/AOG.0b013e3181c3020d · DOI · Paper page
Cited by
CARE guidelines for case reports: explanation and elaboration document
Riley, D. S., Barber, M. S., Kienle, G. S., Aronson, J. K., von Schoen-Angerer, T., Tugwell, P., Kiene, H., Helfand, M., Altman, D. G., Sox, H., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.04.026 · Cited by 2,287
Self-citationAppelbaum, M., Cooper, H., Kline, R. B., Mayo-Wilson, E., Nezu, A. M., & Rao, S. M. (2018) · American Psychologist · doi:10.1037/amp0000191 · Cited by 1,449
Krasny-Pacini, A., & Evans, J. (2018) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2017.12.002 · Cited by 373
CONSORT 2010 statement: extension checklist for reporting within person randomised trials
Pandis, N., Chung, B., Scherer, R. W., Elbourne, D., & Altman, D. G. (2017) · BMJ · doi:10.1136/bmj.j2835 · Cited by 257
Self-citationTate, R. L., Perdices, M., Rosenkoetter, U., McDonald, S., Togher, L., Shadish, W., Horner, R., Kratochwill, T., Barlow, D. H., Kazdin, A., et al. (2016) · Archives of Scientific Psychology · doi:10.1037/arc0000027 · Cited by 219
“The CONSORT Extension for N-of-1 Trials (CENT 2015) was developed for multiple crossover trials with single individuals in the medical sciences (Shamseer et al., 2015; Vohra et al., 2015), but there is no reporting guideline in the CONSORT tradition for single-case research used in the behavioral…”
BackgroundMethodSelf-citation
Metadata
- Authors
- Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Nikles, J., Tate, R., Johnston, B. C., Zucker, D., Shadish, W. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., Vohra, S., Altman, D. G., Bukutu, C., Clark, J., Cogo, E., Gabler, N. B., Guyatt, G., Kravitz, R., Janosky, J., Johnston, B. C., Li, B., Mahon, J., Marles, R., Moher, D., Nikles, J., Sampson, M., Schmid, C. H., Shadish, W. R., Shamseer, L., Tate, R., Vohra, S., & Zucker, D.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 76
- Pages
- 18-46
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W1524110242
- Cited by
- 143
- References
- 24
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. https://app.cochat.ai/papers/10.1016/j.jclinepi.2015.05.018
- The paper
- Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Nikles, J., Tate, R., Johnston, B. C., Zucker, D., Shadish, W. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., Vohra, S., Altman, D. G., Bukutu, C., Clark, J., Cogo, E., Gabler, N. B., . . . Zucker, D. (2016). CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2015.05.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.